Annual EBIT
-$64.85 M
+$48.51 M+42.79%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual earnings before interest & taxes is -$64.85 million, with the most recent change of +$48.51 million (+42.79%) on December 31, 2023.
- During the last 3 years, STRO annual EBIT has fallen by -$36.80 million (-131.19%).
- STRO annual EBIT is now -3910.28% below its all-time high of $1.70 million, reached on December 31, 2016.
Performance
STRO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$40.88 M
-$1.91 M-4.90%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly earnings before interest & taxes is -$40.88 million, with the most recent change of -$1.91 million (-4.90%) on September 30, 2024.
- Over the past year, STRO quarterly EBIT has dropped by -$96.48 million (-173.51%).
- STRO quarterly EBIT is now -173.51% below its all-time high of $55.60 million, reached on December 31, 2023.
Performance
STRO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$73.06 M
-$2.11 M-2.97%
September 30, 2024
Summary
- As of February 7, 2025, STRO TTM earnings before interest & taxes is -$73.06 million, with the most recent change of -$2.11 million (-2.97%) on September 30, 2024.
- Over the past year, STRO TTM EBIT has dropped by -$8.20 million (-12.65%).
- STRO TTM EBIT is now -469.49% below its all-time high of $19.77 million, reached on September 30, 2020.
Performance
STRO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
STRO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.8% | -173.5% | -12.7% |
| 3 y3 years | -131.2% | -173.5% | -12.7% |
| 5 y5 years | -74.2% | -173.5% | -12.7% |
STRO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.8% | -173.5% | +16.3% | -12.7% | +53.1% |
| 5 y | 5-year | -131.2% | +42.8% | -173.5% | +33.9% | -469.5% | +53.1% |
| alltime | all time | -3910.3% | +42.8% | -173.5% | +33.9% | -469.5% | +53.1% |
Sutro Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$40.88 M(+4.9%) | -$73.06 M(+3.0%) |
| Jun 2024 | - | -$38.97 M(-20.2%) | -$70.95 M(+5.9%) |
| Mar 2024 | - | -$48.82 M(-187.8%) | -$67.00 M(+3.3%) |
| Dec 2023 | -$64.85 M(-42.8%) | $55.60 M(-243.4%) | -$64.85 M(-58.4%) |
| Sep 2023 | - | -$38.77 M(+10.7%) | -$155.74 M(+16.5%) |
| Jun 2023 | - | -$35.02 M(-25.0%) | -$133.67 M(+10.0%) |
| Mar 2023 | - | -$46.67 M(+32.3%) | -$121.57 M(+7.2%) |
| Dec 2022 | -$113.36 M(+10.7%) | -$35.29 M(+111.3%) | -$113.36 M(-1.9%) |
| Sep 2022 | - | -$16.70 M(-27.1%) | -$115.58 M(-10.4%) |
| Jun 2022 | - | -$22.92 M(-40.4%) | -$128.97 M(+15.8%) |
| Mar 2022 | - | -$38.45 M(+2.5%) | -$111.35 M(+8.7%) |
| Dec 2021 | -$102.40 M(+265.1%) | -$37.51 M(+24.7%) | -$102.40 M(-19.2%) |
| Sep 2021 | - | -$30.08 M(+467.0%) | -$126.68 M(+64.2%) |
| Jun 2021 | - | -$5.30 M(-82.0%) | -$77.14 M(+97.7%) |
| Mar 2021 | - | -$29.50 M(-52.3%) | -$39.01 M(+39.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$28.05 M(-45.4%) | -$61.80 M(-417.6%) | -$28.05 M(-241.9%) |
| Sep 2020 | - | $19.46 M(-40.7%) | $19.77 M(-272.6%) |
| Jun 2020 | - | $32.83 M(-277.1%) | -$11.46 M(-79.8%) |
| Mar 2020 | - | -$18.54 M(+32.7%) | -$56.84 M(+10.6%) |
| Dec 2019 | -$51.39 M(+38.1%) | -$13.97 M(+18.7%) | -$51.39 M(+24.8%) |
| Sep 2019 | - | -$11.77 M(-6.3%) | -$41.18 M(+5.2%) |
| Jun 2019 | - | -$12.56 M(-4.0%) | -$39.16 M(+1.2%) |
| Mar 2019 | - | -$13.09 M(+248.3%) | -$38.69 M(+3.8%) |
| Dec 2018 | -$37.22 M(+95.9%) | -$3.76 M(-61.5%) | -$37.26 M(-23.0%) |
| Sep 2018 | - | -$9.75 M(-19.3%) | -$48.40 M(+21.5%) |
| Jun 2018 | - | -$12.09 M(+3.6%) | -$39.82 M(+43.6%) |
| Mar 2018 | - | -$11.66 M(-21.7%) | -$27.74 M(+72.6%) |
| Dec 2017 | -$19.00 M(-1216.3%) | -$14.89 M(+1158.7%) | -$16.07 M(+1258.7%) |
| Sep 2017 | - | -$1.18 M | -$1.18 M |
| Dec 2016 | $1.70 M | - | - |
FAQ
- What is Sutro Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sutro Biopharma?
- What is Sutro Biopharma annual EBIT year-on-year change?
- What is Sutro Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sutro Biopharma?
- What is Sutro Biopharma quarterly EBIT year-on-year change?
- What is Sutro Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sutro Biopharma?
- What is Sutro Biopharma TTM EBIT year-on-year change?
What is Sutro Biopharma annual earnings before interest & taxes?
The current annual EBIT of STRO is -$64.85 M
What is the all time high annual EBIT for Sutro Biopharma?
Sutro Biopharma all-time high annual earnings before interest & taxes is $1.70 M
What is Sutro Biopharma annual EBIT year-on-year change?
Over the past year, STRO annual earnings before interest & taxes has changed by +$48.51 M (+42.79%)
What is Sutro Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of STRO is -$40.88 M
What is the all time high quarterly EBIT for Sutro Biopharma?
Sutro Biopharma all-time high quarterly earnings before interest & taxes is $55.60 M
What is Sutro Biopharma quarterly EBIT year-on-year change?
Over the past year, STRO quarterly earnings before interest & taxes has changed by -$96.48 M (-173.51%)
What is Sutro Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of STRO is -$73.06 M
What is the all time high TTM EBIT for Sutro Biopharma?
Sutro Biopharma all-time high TTM earnings before interest & taxes is $19.77 M
What is Sutro Biopharma TTM EBIT year-on-year change?
Over the past year, STRO TTM earnings before interest & taxes has changed by -$8.20 M (-12.65%)